The Barretina datasets [12] also indicated that the expression of SMC2 was increased 3.937-, 3.049-, 2.160- and 2.358-fold in mucinous fibrosarcoma, pleomorphic liposarcoma, circular cell liposarcoma and leiomyosarcoma, respectively. Here, SMC2 is linked to pleomorphic liposarcoma.